Stephanie De Santiago, DNP, AGNP-C, has a doctorate in nursing (DNP) and is an adult-gerontology nurse practitioner at Banner Sun Health Research Institute, where she specializes in movement disorders and cognitive neurology. She is also a faculty associate for the Doctor of Nursing Practice program at Arizona State University.
Parkinson's Today Blog
The Parkinson’s Foundation has provided funding to more than 550 researchers since 2010. These scientists and researchers receive Foundation awards to improve our understanding of Parkinson’s disease (PD), which will ultimately lead us to better treatments and a cure. We recently sat down with nine of them to get the latest highlights of their ongoing PD research:
With cold temperatures and short days, winter may also coincide with feelings of isolation or loneliness. Know that you are not alone. The winter blues are common and can be triggered by the smallest occurrences.
Whether you care for someone who only requires help with basic tasks or for someone who requires daily physical care, utilizing the proper tools can help care partners provide the best support for their loved one with Parkinson’s disease (PD).
One of the only facts we know about Parkinson’s disease (PD) and medical marijuana is that more research is needed to understand the utility of marijuana or cannabis to treat Parkinson’s symptoms.
Does Parkinson’s disease (PD) only affect movement? Can doctors predict its progression? Can stem cells cure Parkinson’s? In this Neuro Talk, our Chief Scientific Officer, James Beck, PhD, debunks seven common myths about Parkinson's disease.
Over the next three years the Parkinson’s Foundation will invest more than $50 million to Parkinson’s disease (PD) research and clinical care. At the heart of our research initiatives are scientists and researchers who have received Foundation awards to improve our understanding of Parkinson’s, which will ultimately lead us to a cure.
Men are more likely to develop Parkinson’s disease (PD) than women, and the onset of PD in men happens at a younger age. However, women with PD have a higher mortality rate, and once they have Parkinson’s, progression is faster. Research suggests that women get the disease at later in life when compared to men, at least in part, due to the natural protection estrogen provides.
New Year’s resolutions are an opportunity for reflection, change and improvement. Take the time to plan for the year ahead with a fresh, clear outlook. These attainable goals for 2020 can give you inspiration while highlighting exactly how you can get started.
The past two weeks have offered more definitive information on Nilotinib (Tasigna), a drug already approved for treatment of leukemia, as a potential treatment for Parkinson’s disease (PD) symptoms. On December 16, JAMA Neurology published the results of a Phase II safety trial ― a study that tests the effectiveness of a drug or treatment in a larger group of people. Study findings revealed that Nilotinib had more adverse events than the placebo (a pill not containing an active drug) but was reasonably safe.